Prof. Carreira’s spin-off in the news
- D-CHAB
- LOC
An article of the NZZ about five startup companies features the ETHZ spin-off Glycemicon and its improved treatment possibilities of diabetes. Glycemicon is co-founded by Prof Erick M. Carreira.
by
Joachim Schnabl